rss
Ann Rheum Dis doi:10.1136/ard.2008.091710

Systemic sclerosis and its pulmonary complications in the Netherlands An epidemiological study

  1. M C Vonk (m.vonk{at}reuma.umcn.nl)
  1. Radboud University Nijmegen Medical Centre, Netherlands
    1. B Broers MD
    1. Academic Hospital Maastricht, Netherlands
      1. Y F Heijdra
      1. Radboud University Nijmegen Medical Centre, Netherlands
        1. E Ton
        1. University Medical Centre Utrecht, Netherlands
          1. R Snijders
          1. Antonius Hospital Nieuwegein, Netherlands
            1. A PJ van Dijk
            1. Radboud University Nijmegen Medical Centre, Netherlands
              1. J M van Laar
              1. Radboud University Nijmegen Medical Centre, Netherlands
                1. H Bootsma
                1. University Medical Centre Groningen, Netherlands
                  1. P Th W van Hal
                  1. Erasmus Medical Centre Rotterdam, Netherlands
                    1. F HJ van den Hoogen
                    1. Radboud University Nijmegen Medical Centre, Netherlands
                      1. P LA van Daele
                      1. Erasmus Medical Centre Rotterdam, Netherlands
                        • Published Online First 29 May 2008

                        Abstract

                        The prevalence and incidence of systemic sclerosis (SSc) in the Netherlands is unknown. The same holds true for its leading causes of death: pulmonary fibrosis and pulmonary arterial hypertension (PAH), for which effective treatment options have become available recently.

                        Objective: to establish the prevalence and incidence of SSc and its pulmonary complications.

                        Methods: detailed information of patients in the POEMAS registry, “Pulmonary Hypertension Screening, a Multidisciplinary Approach in Scleroderma”, consisting of 819 patients, was combined with a nationwide questionnaire.

                        Results: By combining the two sources we found the prevalence of SSc to be 8.9 per 105 adults. The incidence was 0.77 patients per 105 per year. PAH was diagnosed in 9.9% of the SSc patients. The prevalence of interstitial lung disease in SSc varied from 19 to 47% depending on the definition used.

                        Conclusion: This study clarifies the epidemiology of SSc in the Netherlands and confirms the frequent occurrence of pulmonary complications, based on 654 cases. This can and will be further studied in the ongoing POEMAS study.

                        This Article

                        1. Abstract
                        2. PDF
                        3. All versions of this article:
                          1. ard.2008.091710v1
                          2. ard.2008.091710v2
                          3. 68/6/961most recent

                        Responses

                        1. Submit a response
                        2. No responses published

                        Register for free content

                        The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

                        Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.